A Framework for Using Cost‐effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence

Activity: Talk or presentationInvited talk

Period27 May 2025
Held atUniversity of Bristol, United Kingdom